What could CMS rating methodology changes mean for the Medicare program?
CMS rating changes may alter financial incentives within Medicare The Centers for Medicare & Medicaid Services (CMS) uses star ratings to measure the quality and performance of Medicare Advantage plans. These scores are highly consequential because they determine whether insurers qualify for federal bonus payments and rebates, which translate directly to earnings within the Medicare program. When CMS changes its rating methodology, as seen in legal challenges involving Elevance Health, Inc., the financial stability and operational structure of the program are affected. The resulting legal battles and financial shifts force managed care providers to focus on operational improvements rather than relying on legal remedies to preserve profits.
- Effect
- Strong negative
- How direct
- Stated in the reporting
- When
- Over the long term
- The story
- Gone quiet
How it reaches Medicare
-
Elevance Health, Inc. lost a legal bid to improve its Medicare Advantage quality ratings for 2025 after a federal judge rejected its challenge against Centers for Medicare and Medicaid Services. This ruling means Elevance Health, Inc. estimates it will forgo at least $375 million in bonus payments and rebates. Separately, Alignment Healthcare announced its new Central Health Harmony Medicare Advantage plan will be available in Los Angeles and Orange counties starting January 1, 2027.
The full event5independent outlets -
CMS issues star ratings to reflect plan quality, and these scores are highly consequential for Medicare. They not only determine whether insurers qualify for federal bonus payments but also influence consumer perceptions and enrollment within the Medicare program.
2 reports connect these two. Brind only summarizes; follow a link to read the reporting itself.
- Zacks Elevance Shoots for the Stars But Lands at 3.5: $375M Bonus Gone? Elevance Health, Inc. ELV recently encountered a significant legal blow after a federal judge dismissed its challenge against the U.SAug 22
- Healthcare Dive Elevance loses Medicare Advantage star ratings suit This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter.Aug 20
-
US federal health insurance
Everything about Medicare
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- Lower star ratings cost Elevance Health, Inc. at least $375 million in bonus payments and rebates.Zacks, Healthcare Dive
- Plans receiving an overall rating of four or higher receive higher bonus payments.Healthcare Dive
- CMS determines star ratings through calculations related to access, plan communication, patient experience and outcomes.Healthcare Dive
- CMS has expanded its team of medical coders from 40 to 2,000 amid regulatory scrutiny.PR Newswire
Why it matters
The star ratings are a core mechanism of the Medicare program, serving as both a quality metric and a financial lever for the privatized system. When the methodology used to assign these ratings is challenged in court, it introduces significant regulatory risk that can destabilize the financial incentives that drive the Medicare Advantage market. This uncertainty affects the ability of insurers to maintain stable profits and plan margins.
The reports show that multiple insurers, including Centene Corporation and Humana Inc., have pursued legal challenges following methodology updates that caused rating declines. This pattern highlights that the relationship between CMS and the managed care providers is highly contentious, with insurers viewing the ratings as essential to preserving their market position and profits.
What we don't know yet
- Will the legal challenges against CMS succeed in altering the rating methodology?
- How will insurers adapt their operational plans to mitigate the financial risks associated with rating volatility?
Is this still moving?
- Reports
- 9
- Developments
- 9
- Repetition
- 44%
What would change this answer
— Other considerations
Beyond this explainer
Questions worth asking
Ideas the web ties closely to this story that the explainer doesn't mention. These are prompts for your own research: Brind hasn't answered them.
-
About Quality Improvement Organization
Since CMS ratings rely on quality metrics, how do Quality Improvement Organizations contribute data that feeds into the star rating calculations?
-
About Esrd
Given that CMS ratings consider patient outcomes, how do care plans manage the specific challenges and costs associated with End-Stage Renal Disease patients?
-
About Fee for service ffs
How does the traditional Fee-For-Service payment model differ from the value-based incentives used in Medicare Advantage, and how might this difference influence rating methodology?
Explore connected ideas
Each opens in Related concepts: what the web connects to it, with Brind's news on it.
The ideas come from how millions of web pages place them near each other. The questions are Brind's AI reasoning, written only from this explainer and Brind's own reporting.
Who else could feel it
Other possible ripples from the same event.
Reporting
- ZacksAug 22
- Healthcare DiveAug 20
- financialcontent.comOct 12
- StockStoryAug 12
- PR NewswireJul 16
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.